Global Cell and Gene Therapy Market Size & Trends Report Segmented by Therapy Type (Cell, Gene), Indication (Oncology, Autoimmune Diseases, Others), End-user (Hospitals, Specialty Centers, Others) & Regional Forecasts to 2030
The global cell and gene therapy market is experiencing significant expansion, driven by rising approvals and advancements in treatment modalities. The market is projected to grow at a compound annual growth rate of ~23% over the forecast period. This rapid growth is fueled by increasing investments in biopharmaceutical R&D, favorable regulatory support, and expanding clinical applications of gene-modified and cell-based treatments. To learn more about the research report, download a sample report.
Report Overview
Cell and gene therapy represent two transformative approaches in modern medicine to treat or potentially cure diseases at their root cause. Cell therapy involves the transplantation or modifying living cells to restore or enhance their function, often used for regenerative medicine and immunotherapy applications. Gene therapy, on the other hand, focuses on modifying or replacing faulty genes to correct genetic disorders, cancers, and other chronic conditions. These therapies hold immense promise for conditions previously considered untreatable, driving extensive research and commercial interest.
To learn more about this report, download the PDF brochure
The expanding applications of CAR-T cell therapy to drive market growth
CAR-T (Chimeric Antigen Receptor T-cell) therapy is revolutionizing the treatment of hematologic cancers, significantly boosting the demand for cell and gene therapies. This therapy involves modifying a patient’s T cells to express a receptor specific to cancer cells, allowing for precise and potent immune responses. The dramatic success of CAR-T therapies in treating relapsed or refractory leukemias and lymphomas have fueled their rapid adoption. Regulatory agencies have granted approvals for multiple CAR-T therapies, and ongoing clinical trials are expanding applications into solid tumours and autoimmune disorders. Additionally, advancements in allogeneic (off-the-shelf) CAR-T therapies aim to overcome existing challenges related to patient-specific manufacturing. As CAR-T therapies' efficacy and safety profiles improve, they are expected to play a central role in the broader adoption of cell and gene therapies, enhancing patient outcomes and market growth.
Next-generation gene editing technologies enhancing precision and accessibility
Innovations in gene editing, particularly CRISPR-Cas9 and base editing, are revolutionizing the field of gene therapy by enabling highly precise genetic modifications. CRISPR technology allows targeted corrections of faulty genes with minimal off-target effects, significantly improving treatment safety and effectiveness. Furthermore, newer gene-editing platforms, such as prime editing, offer enhanced control over genetic alterations, expanding therapeutic possibilities for rare genetic disorders and cancers. The integration of artificial intelligence (AI) in gene editing is also accelerating the discovery of novel therapeutic targets and improving editing efficiency. Additionally, advancements in non-viral delivery methods, such as lipid nanoparticles, are making gene therapy more scalable and accessible. As these technologies continue to evolve, they are expected to drive a new wave of gene-based therapies, improving affordability, regulatory acceptance, and widespread clinical adoption across diverse therapeutic areas.
To learn more about this report, download the PDF brochure
Competitive Landscape Analysis
The global cell and gene therapy market is marked by the presence of established and emerging market players such as Sartorius AG; Novartis AG; Thermo Fisher Scientific, Inc.; Merck KGaA; Charles River Laboratories; Cell and Gene Therapy Catapult; Lonza; WuXi AppTec; Takara Bio Inc.; Bristol Myers Squibb; FUJIFILM Holdings Corporation; and F. Hoffmann-La Roche Ltd. among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.
Report Scope
| Report Metric | Details |
| Base Year Considered | 2024 |
| Historical Data | 2023 - 2024 |
| Forecast Period | 2025 – 2030 |
| Growth Rate | 23% |
| Market Drivers |
|
| Attractive Opportunities |
|
| Segment Scope | Therapy Type, Indication, and End-user |
| Regional Scope |
|
| Key Companies Mapped | Sartorius AG; Novartis AG; Thermo Fisher Scientific, Inc.; Merck KGaA; Charles River Laboratories; Cell and Gene Therapy Catapult; Lonza; WuXi AppTec; Takara Bio Inc.; Bristol Myers Squibb; FUJIFILM Holdings Corporation; and F. Hoffmann-La Roche Ltd. among others |
| Report Highlights | Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Global Cell and Gene Therapy Market Segmentation
This report by Medi-Tech Insights provides the size of the global cell and gene therapy market at the regional- and country-level from 2023 to 2030. The report further segments the market based on therapy type, indication, and end-user.
Market Size & Forecast (2023-2030), By Therapy Type, USD Million
- Cell Therapy
- Gene Therapy
Market Size & Forecast (2023-2030), By Indication, USD Million
- Oncology
- Autoimmune Diseases
- Neurological Diseases
- Cardiovascular Diseases
- Others
Market Size & Forecast (2023-2030), By End-user, USD Million
- Hospitals & Speciality Clinics
- Pharma & Biotech Companies
- Academic Research Institutes
- Others
Market Size & Forecast (2023-2030), By Region, USD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Key Strategic Questions Addressed
- What is the market size & forecast of the cell & gene therapy market?
- What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the cell & gene therapy market?
- What are the key trends defining the market?
- What are the major factors impacting the market?
- What are the opportunities prevailing in the market?
- Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
- Who are the major players operating in the market?
- What are the key strategies adopted by players?
- Introduction
- Introduction
- Market Scope
- Market Definition
- Segments Covered
- Regional Segmentation
- Research Timeframe
- Currency Considered
- Study Limitations
- Stakeholders
- List of Abbreviations
- Key Conferences and Events (2025-2026)
- Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
- Bottom-Up Approach
- Top-Down Approach
- Market Forecasting
- Executive Summary
- Cell and Gene Therapy Market Snapshot (2025-2030)
- Segment Overview
- Regional Snapshot
- Competitive Insights
- Market Overview
- Market Dynamics
- Drivers
- Rising prevalence of genetic disorders and cancers
- Expanding applications of CAR-T and stem cell therapies
- Increasing approvals from regulatory agencies
- Advancements in gene editing technologies
- Personalized medicine and precision therapies gaining traction
- Restraints
- High cost of treatment and complex manufacturing processes
- Challenges in long-term safety and efficacy assessments
- Regulatory and ethical concerns surrounding gene modifications
- Opportunities
- Expansion of allogeneic (off-the-shelf) cell therapies
- Integration of AI in gene therapy research and drug development
- Rising demand for regenerative medicine applications
- Growing investments from biotech firms and pharmaceutical giants
- Key Market Trends
- Development of next-generation viral and non-viral gene delivery systems
- Increasing focus on combination therapies
- Adoption of decentralized manufacturing models for cell therapy
- Unmet Market Needs
- Industry Speaks
- Pipeline Analysis
- Drivers
- Market Dynamics
- Global Cell and Gene Therapy Market Size & Forecast (2023-2030), By Therapy Type, USD Million
- Introduction
- Cell Therapy
- Gene Therapy
- Global Cell and Gene Therapy Market Size & Forecast (2023-2030), By Indication, USD Million
- Introduction
- Oncology
- Autoimmune Diseases
- Neurological Diseases
- Cardiovascular Diseases
- Others
- Global Cell and Gene Therapy Market Size & Forecast (2023-2030), By End-user, USD Million
- Introduction
- Hospitals & Speciality Clinics
- Pharma & Biotech Companies
- Academic Research Institutes
- Others
- Global Cell and Gene Therapy Market Size & Forecast (2023-2030), By Region, USD Million
- Introduction
- North America Cell and Gene Therapy Market Size & Forecast (2023-2030), By Country, USD Million
- US
- Market Size & Forecast, By Therapy Type (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Canada
- Market Size & Forecast, By Therapy Type (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- US
- Europe Cell and Gene Therapy Market Size & Forecast (2023-2030), By Country, USD Million
- UK
- Market Size & Forecast, By Therapy Type (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Germany
- Market Size & Forecast, By Therapy Type (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- France
- Market Size & Forecast, By Therapy Type (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Italy
- Market Size & Forecast, By Therapy Type (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Spain
- Market Size & Forecast, By Therapy Type (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Rest of Europe
- Market Size & Forecast, By Therapy Type (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- UK
- Asia Pacific (APAC) Cell and Gene Therapy Market Size & Forecast (2023-2030), By Country, USD Million
- China
- Market Size & Forecast, By Therapy Type (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Japan
- Market Size & Forecast, By Therapy Type (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- India
- Market Size & Forecast, By Therapy Type (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Rest of Asia Pacific
- Market Size & Forecast, By Therapy Type (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- China
- Latin America (LATAM) Cell and Gene Therapy Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Therapy Type (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Middle East & Africa (MEA) Cell and Gene Therapy Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Therapy Type (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Competitive Landscape
- Key Players and their Competitive Positioning
- Key Player Comparison
- Segment-wise Player Mapping
- Market Share Analysis (2024)
- Company Categorization Matrix
- Dominants/Leaders
- New Entrants
- Emerging Players
- Innovative Players
- Key Strategies Assessment, By Player (2022-2025)
- New Product Launch/Approval
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Key Players and their Competitive Positioning
- Company Profiles*
(Business Overview, Financial Performance**, Products Offered, Recent Developments)
- Sartorius AG; Novartis AG
- Thermo Fisher Scientific, Inc.
- Merck KGaA
- Charles River Laboratories
- Cell and Gene Therapy Catapult
- Lonza
- WuXi AppTec
- Takara Bio Inc.
- Bristol Myers Squibb
- FUJIFILM Holdings Corporation
- Other Prominent Players
Note: *Indicative list
**For listed companies
The study has been compiled based on extensive primary and secondary research.
Secondary Research (Indicative List)
Primary Research
To validate research findings (market size & forecasts, market segmentation, market dynamics, competitive landscape, key industry trends, etc.), extensive primary interviews were conducted with both supply and demand-side stakeholders.
Supply Side Stakeholders:
- Senior Management Level: CEOs, Presidents, Vice-Presidents, Directors, Chief Technology Officers, Chief Commercial Officers
- Mid-Management Level: Product Managers, Sales Managers, Brand Managers, R&D Managers, Business Development Managers, Consultants
Demand Side Stakeholders:
- Stakeholders from Hospitals & Speciality Clinics, Pharma & Biotech Companies, Academic Research Institutes and Others
Breakdown of Primary Interviews
Market Size Estimation
Both ‘Top-Down & Bottom-Up Approaches’ were used to derive market size estimates and forecasts
Data Triangulation
Research findings derived through secondary sources & internal analysis was validated with Primary Interviews, Internal Knowledge Repository and Company’s Sales Data
